GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ims Health Holdings Inc. (IMS) [hlAlert]

Rating:
Buy IMS
up 10.07 %

Ims Health Holdings Inc. (IMS) rated Buy with price target $35 by Topeka Capital Markets

Posted on: Monday,  Jun 22, 2015  8:25 AM ET by Topeka Capital Markets

Topeka Capital Markets rated Buy Ims Health Holdings Inc. (NYSE: IMS) on 06/22/2015. Previously Topeka Capital Markets rated Buy Ims Health Holdings Inc. (NYSE:
IMS) on 09/24/2014., when the stock price was $27.09. Since then, Ims Health Holdings Inc. has gained 10.08% as of 01/26/2016's recent price of $29.82.
If you would have followed the previous Topeka Capital Markets's recommendation on IMS, you would have gained 10.07% of your investment in 489 days.

Morgan Stanley Insured Municipal Securities (the Trust) is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income, which is exempt from federal income tax. Morgan Stanley Insured Municipal Securities' portfolio includes tax-exempt municipal bonds and short-term investments. It may invest a portion of its assets in inverse floating-rate instruments. The Trust may invest in put and call options, and futures on its portfolio securities. It invests in sectors, such as water and sewer, public power and airports. The Trust invests in Morgan Stanley Institutional Liquidity Tax-Exempt Portfolio-Institutional Class, an open-end management investment company managed by the Trust's investment advisor, Morgan Stanley Investment Advisors Inc. The Trust's administrator is Morgan Stanley Services Company Inc.

Topeka Capital Markets
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/22/2015 8:25 AM Buy
None
31.71 35.00
as of 8/27/2015
1 Week down  -0.66 %
1 Month down  -6.72 %
3 Months up  1.84 %
1 YTD down  -5.96 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/24/2014 8:25 AM Buy
None
27.09 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy